Induction immunosuppression in liver transplantation: a review (Q38104751)

28 August 2017

Induction immunosuppression in liver transplantation: a review (English)

1 reference

28 August 2017

1 reference

liver transplantation

1 reference

Alexandra P Turner

1

1 reference

PubMed ID

23651083

28 August 2017

Stuart J Knechtle

series ordinal

2

1 reference

28 August 2017

8 May 2013

1 reference

28 August 2017

Transplant International

1 reference

28 August 2017

26

1 reference

28 August 2017

7

1 reference

28 August 2017

673-683

1 reference

Rabbit antithymocyte globulin versus basiliximab in renal transplantation

28 August 2017

1 reference

Induction immunosuppression improves long-term graft and patient outcome in organ transplantation: an analysis of United Network for Organ Sharing registry data

21 January 2018

1 reference

Alemtuzumab induction in renal transplantation

21 January 2018

1 reference

Campath-1H induction plus rapamycin monotherapy for renal transplantation: results of a pilot study.

21 January 2018

1 reference

Thymoglobulin induction in liver transplant recipients with a tacrolimus, mycophenolate mofetil, and steroid immunosuppressive regimen: a five-year randomized prospective study

21 January 2018

1 reference

Thymoglobulin induction protects liver allografts from ischemia/reperfusion injury

21 January 2018

1 reference

Interleukin-2 receptor antagonists in liver transplantation: a meta-analysis of randomized trials

21 January 2018

1 reference

Improved treatment response with basiliximab immunoprophylaxis after liver transplantation: results from a double-blind randomized placebo-controlled trial

21 January 2018

1 reference

Unique histopathological features of graft biopsies with liver function abnormalities in living donor liver transplant patients receiving basiliximab induction therapy.

21 January 2018

1 reference

Daclizumab induction therapy associated with tacrolimus-MMF has better outcome compared with tacrolimus-MMF alone in pediatric living donor liver transplantation

21 January 2018

1 reference

The impact of Campath 1H induction in adult liver allotransplantation

21 January 2018

1 reference

Preliminary experience with alemtuzumab (Campath-1H) and low-dose tacrolimus immunosuppression in adult liver transplantation

21 January 2018

1 reference

Pediatric liver transplant with Campath 1H induction--Preliminary report

21 January 2018

1 reference

Long-term renal function after liver transplantation is related to calcineurin inhibitors blood levels

21 January 2018

1 reference

Kidney dysfunction in the recipients of liver transplants

21 January 2018

1 reference

End-stage renal disease (ESRD) after orthotopic liver transplantation (OLTX) using calcineurin-based immunotherapy: risk of development and treatment

21 January 2018

1 reference

Chronic renal failure after transplantation of a nonrenal organ

21 January 2018

1 reference

Chronic renal dysfunction late after liver transplantation

21 January 2018

1 reference

Use of daclizumab as initial immunosuppression in liver transplant recipients with impaired renal function

21 January 2018

1 reference

Two-dose daclizumab induction therapy in 209 liver transplants: a single-center analysis

21 January 2018

1 reference

Delayed introduction of reduced-dose tacrolimus, and renal function in liver transplantation: the 'ReSpECT' study.

21 January 2018

1 reference

Assessing renal function with daclizumab induction and delayed tacrolimus introduction in liver transplant recipients

21 January 2018

1 reference

Trough tacrolimus concentrations in the first week after kidney transplantation are related to acute rejection.

21 January 2018

1 reference

A randomized trial comparing renal function in older kidney transplant patients following delayed versus immediate tacrolimus administration

21 January 2018

1 reference

Tolerogenic immunosuppression for organ transplantation

21 January 2018

1 reference

ATG-Fresenius treatment and low-dose tacrolimus: results of a randomized controlled trial in liver transplantation.

21 January 2018

1 reference

Acute liver transplant rejection upon immunosuppression withdrawal in a tolerance induction trial: potential role of IFN-gamma-secreting CD8+ T cells.

21 January 2018

1 reference

Tolerance: is it worth the risk?

21 January 2018

1 reference

Preserving renal function in liver transplant recipients with rabbit anti-thymocyte globulin and delayed initiation of calcineurin inhibitors

21 January 2018

1 reference

Steroid avoidance in liver transplantation: meta-analysis and meta-regression of randomized trials

21 January 2018

1 reference

Recurrent hepatitis C after liver transplantation

21 January 2018

1 reference

Steroid withdrawal at day 14 after liver transplantation: a double-blind, placebo-controlled study

21 January 2018

1 reference

Fibrosis progression after liver transplantation in patients with recurrent hepatitis C.

21 January 2018

1 reference

Impact of immunosuppression without steroids on rejection and hepatitis C virus evolution after liver transplantation: results of a prospective randomized study

21 January 2018

1 reference

Immunosuppression without steroids in liver transplantation is safe and reduces infection and metabolic complications: results from a prospective multicenter randomized study

21 January 2018

1 reference

Corticosteroid-free immunosuppression with tacrolimus following induction with daclizumab: a large randomized clinical study

21 January 2018

1 reference

A prospective randomized open study in liver transplant recipients: daclizumab, mycophenolate mofetil, and tacrolimus versus tacrolimus and steroids

21 January 2018

1 reference

Corticosteroid-free immunosuppression with daclizumab in HCV(+) liver transplant recipients: 1-year interim results of the HCV-3 study

21 January 2018

1 reference

Double-blind comparison of hepatitis C histological recurrence Rate in HCV+ Liver transplant recipients given basiliximab + steroids or basiliximab + placebo, in addition to cyclosporine and azathioprine.

21 January 2018

1 reference

Review article: use of induction therapy in liver transplantation

21 January 2018

1 reference

Use of alemtuzumab and tacrolimus monotherapy for cadaveric liver transplantation: with particular reference to hepatitis C virus

21 January 2018

1 reference

Time trends in risk and risk determinants of non-Hodgkin lymphoma in solid organ transplant recipients.

21 January 2018

1 reference

Posttransplant lymphoproliferative disorders after renal transplantation in the United States in era of modern immunosuppression

21 January 2018

1 reference

Patient outcomes in two steroid-free regimens using tacrolimus monotherapy after daclizumab induction and tacrolimus with mycophenolate mofetil in liver transplantation

21 January 2018

1 reference

Early steroid-free immunosuppression with FK506 after liver transplantation: long-term results of a prospectively randomized double-blinded trial

21 January 2018

1 reference

Interleukin 2 receptor antagonists for liver transplant recipients: a systematic review and meta-analysis of controlled studies

21 January 2018

1 reference

Interleukin-2 receptor antibody (basiliximab) for immunosuppressive induction therapy after liver transplantation: a protocol with early elimination of steroids and reduction of tacrolimus dosage

21 January 2018

1 reference

Improved outcome after 'bottom-up' immunosuppression in liver transplant recipients with preoperative renal impairment

21 January 2018

1 reference

Study protocol: a pilot study to determine the safety and efficacy of induction-therapy, de novo MPA and delayed mTOR-inhibition in liver transplant recipients with impaired renal function. PATRON-study

21 January 2018

1 reference

Steroid-free, tacrolimus-basiliximab immunosuppression in pediatric liver transplantation: clinical and pharmacoeconomic study in 50 children.

21 January 2018

1 reference

Anti-lymphocyte therapy successfully controls late "cholestatic" rejection in pediatric liver transplant recipients

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/TRI.12100

1 reference

28 August 2017

1 reference

PubMed ID

23651083